Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06833450

Reliability of IUS in Crohn's Disease

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
Centre Hospitalier Universitaire, Amiens · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Transabdominal intestinal ultrasound (IUS) is gaining acceptance as a point-of-care test to objectively assess disease activity in Crohn's disease (CD). In order to incorporate individual parameters in a future definition of transmural healing, and for the consistent application of IUS as a modality to assess treatment outcomes and establish therapeutic targets to ensure comparability between future studies, the inter-observer agreement should be determined for all relevant parameters.

Conditions

Interventions

TypeNameDescription
OTHERTransabdominal intestinal ultrasoundTransabdominal intestinal ultrasound

Timeline

Start date
2022-01-19
Primary completion
2026-02-01
Completion
2026-02-01
First posted
2025-02-18
Last updated
2025-02-18

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT06833450. Inclusion in this directory is not an endorsement.